[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Large Volume Parenteral (LVP) Market Growth 2020-2025

August 2020 | 164 pages | ID: GC05EA4207BEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, over the next five years the Large Volume Parenteral (LVP) market will register a 9.1%% CAGR in terms of revenue, the global market size will reach $ 14850 million by 2025, from $ 10470 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Large Volume Parenteral (LVP) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Large Volume Parenteral (LVP) market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Large Volume Parenteral (LVP), covering the supply chain analysis, impact assessment to the Large Volume Parenteral (LVP) market size growth rate in several scenarios, and the measures to be undertaken by Large Volume Parenteral (LVP) companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
  • Soft Bag LVP
  • Plastic Bottle LVP
  • Glass Bottle LVP
  • In 2018, Soft Bag LVP accounted for a major share of 61% in the global Large Volume Parenteral (LVP) market. And this product segment is poised to reach 15402 M Units by 2024 from 13868 M Units in 2019.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
  • Basic Infusion
  • Therapeutic Infusion
  • Nutritious Infusion
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
  • Baxter Healthcare
  • Huaren
  • Kelun Pharma
  • Fresenius
  • Teva Pharmaceutical Industries
  • B. Braun
  • CR Double-Crane
  • Pfizer (Hospira)
  • Pisa
  • Ostuka Pharmaceutical
  • PSI Ltd
  • BAG Healthcare
  • Ozon Pharmaceuticals
  • Patheon
  • Cook Pharmica
  • Beximco Pharma
  • Albert David
  • Aspen Holdings
  • BML Parenteral Drugs
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Large Volume Parenteral (LVP) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
  • To understand the structure of Large Volume Parenteral (LVP) market by identifying its various subsegments.
  • Focuses on the key global Large Volume Parenteral (LVP) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Large Volume Parenteral (LVP) with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Large Volume Parenteral (LVP) submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Large Volume Parenteral (LVP) Consumption 2015-2025
  2.1.2 Large Volume Parenteral (LVP) Consumption CAGR by Region
2.2 Large Volume Parenteral (LVP) Segment by Type
  2.2.1 Soft Bag LVP
  2.2.2 Plastic Bottle LVP
  2.2.3 Glass Bottle LVP
2.3 Large Volume Parenteral (LVP) Consumption by Type
  2.3.1 Global Large Volume Parenteral (LVP) Consumption Market Share by Type (2015-2020)
  2.3.2 Global Large Volume Parenteral (LVP) Revenue and Market Share by Type (2015-2020)
  2.3.3 Global Large Volume Parenteral (LVP) Sale Price by Type (2015-2020)
2.4 Large Volume Parenteral (LVP) Segment by Application
  2.4.1 Basic Infusion
  2.4.2 Therapeutic Infusion
  2.4.3 Nutritious Infusion
2.5 Large Volume Parenteral (LVP) Consumption by Application
  2.5.1 Global Large Volume Parenteral (LVP) Consumption Market Share by Type (2015-2020)
  2.5.2 Global Large Volume Parenteral (LVP) Value and Market Share by Type (2015-2020)
  2.5.3 Global Large Volume Parenteral (LVP) Sale Price by Type (2015-2020)

3 GLOBAL LARGE VOLUME PARENTERAL (LVP) BY COMPANY

3.1 Global Large Volume Parenteral (LVP) Sales Market Share by Company
  3.1.1 Global Large Volume Parenteral (LVP) Sales by Company (2018-2020)
  3.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Company (2018-2020)
3.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Company
  3.2.1 Global Large Volume Parenteral (LVP) Revenue by Company (2018-2020)
  3.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Company (2018-2020)
3.3 Global Large Volume Parenteral (LVP) Sale Price by Company
3.4 Global Large Volume Parenteral (LVP) Manufacturing Base Distribution, Sales Area, Type by Company
  3.4.1 Global Large Volume Parenteral (LVP) Manufacturing Base Distribution and Sales Area by Company
  3.4.2 Players Large Volume Parenteral (LVP) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 LARGE VOLUME PARENTERAL (LVP) BY REGIONS

4.1 Large Volume Parenteral (LVP) by Regions
4.2 Americas Large Volume Parenteral (LVP) Consumption Growth
4.3 APAC Large Volume Parenteral (LVP) Consumption Growth
4.4 Europe Large Volume Parenteral (LVP) Consumption Growth
4.5 Middle East & Africa Large Volume Parenteral (LVP) Consumption Growth

5 AMERICAS

5.1 Americas Large Volume Parenteral (LVP) Consumption by Countries
  5.1.1 Americas Large Volume Parenteral (LVP) Consumption by Countries (2015-2020)
  5.1.2 Americas Large Volume Parenteral (LVP) Value by Countries (2015-2020)
5.2 Americas Large Volume Parenteral (LVP) Consumption by Type
5.3 Americas Large Volume Parenteral (LVP) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Large Volume Parenteral (LVP) Consumption by Regions
  6.1.1 APAC Large Volume Parenteral (LVP) Consumption by Regions (2015-2020)
  6.1.2 APAC Large Volume Parenteral (LVP) Value by Regions (2015-2020)
6.2 APAC Large Volume Parenteral (LVP) Consumption by Type
6.3 APAC Large Volume Parenteral (LVP) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 EUROPE

7.1 Europe Large Volume Parenteral (LVP) by Countries
  7.1.1 Europe Large Volume Parenteral (LVP) Consumption by Countries (2015-2020)
  7.1.2 Europe Large Volume Parenteral (LVP) Value by Countries (2015-2020)
7.2 Europe Large Volume Parenteral (LVP) Consumption by Type
7.3 Europe Large Volume Parenteral (LVP) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Large Volume Parenteral (LVP) by Countries
  8.1.1 Middle East & Africa Large Volume Parenteral (LVP) Consumption by Countries (2015-2020)
  8.1.2 Middle East & Africa Large Volume Parenteral (LVP) Value by Countries (2015-2020)
8.2 Middle East & Africa Large Volume Parenteral (LVP) Consumption by Type
8.3 Middle East & Africa Large Volume Parenteral (LVP) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Channels
  10.1.2 Indirect Channels
10.2 Large Volume Parenteral (LVP) Distributors
10.3 Large Volume Parenteral (LVP) Customer

11 GLOBAL LARGE VOLUME PARENTERAL (LVP) MARKET FORECAST

11.1 Global Large Volume Parenteral (LVP) Consumption Forecast (2021-2025)
11.2 Global Large Volume Parenteral (LVP) Forecast by Regions
  11.2.1 Global Large Volume Parenteral (LVP) Forecast by Regions (2021-2025)
  11.2.2 Global Large Volume Parenteral (LVP) Value Forecast by Regions (2021-2025)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Large Volume Parenteral (LVP) Forecast by Type
11.8 Global Large Volume Parenteral (LVP) Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Baxter Healthcare
  12.1.1 Company Information
  12.1.2 Large Volume Parenteral (LVP) Product Offered
  12.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.1.4 Main Business Overview
  12.1.5 Baxter Healthcare Latest Developments
12.2 Huaren
  12.2.1 Company Information
  12.2.2 Large Volume Parenteral (LVP) Product Offered
  12.2.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.2.4 Main Business Overview
  12.2.5 Huaren Latest Developments
12.3 Kelun Pharma
  12.3.1 Company Information
  12.3.2 Large Volume Parenteral (LVP) Product Offered
  12.3.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.3.4 Main Business Overview
  12.3.5 Kelun Pharma Latest Developments
12.4 Fresenius
  12.4.1 Company Information
  12.4.2 Large Volume Parenteral (LVP) Product Offered
  12.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.4.4 Main Business Overview
  12.4.5 Fresenius Latest Developments
12.5 Teva Pharmaceutical Industries
  12.5.1 Company Information
  12.5.2 Large Volume Parenteral (LVP) Product Offered
  12.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.5.4 Main Business Overview
  12.5.5 Teva Pharmaceutical Industries Latest Developments
12.6 B. Braun
  12.6.1 Company Information
  12.6.2 Large Volume Parenteral (LVP) Product Offered
  12.6.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.6.4 Main Business Overview
  12.6.5 B. Braun Latest Developments
12.7 CR Double-Crane
  12.7.1 Company Information
  12.7.2 Large Volume Parenteral (LVP) Product Offered
  12.7.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.7.4 Main Business Overview
  12.7.5 CR Double-Crane Latest Developments
12.8 Pfizer (Hospira)
  12.8.1 Company Information
  12.8.2 Large Volume Parenteral (LVP) Product Offered
  12.8.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.8.4 Main Business Overview
  12.8.5 Pfizer (Hospira) Latest Developments
12.9 Pisa
  12.9.1 Company Information
  12.9.2 Large Volume Parenteral (LVP) Product Offered
  12.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.9.4 Main Business Overview
  12.9.5 Pisa Latest Developments
12.10 Ostuka Pharmaceutical
  12.10.1 Company Information
  12.10.2 Large Volume Parenteral (LVP) Product Offered
  12.10.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.10.4 Main Business Overview
  12.10.5 Ostuka Pharmaceutical Latest Developments
12.11 PSI Ltd
  12.11.1 Company Information
  12.11.2 Large Volume Parenteral (LVP) Product Offered
  12.11.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.11.4 Main Business Overview
  12.11.5 PSI Ltd Latest Developments
12.12 BAG Healthcare
  12.12.1 Company Information
  12.12.2 Large Volume Parenteral (LVP) Product Offered
  12.12.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.12.4 Main Business Overview
  12.12.5 BAG Healthcare Latest Developments
12.13 Ozon Pharmaceuticals
  12.13.1 Company Information
  12.13.2 Large Volume Parenteral (LVP) Product Offered
  12.13.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.13.4 Main Business Overview
  12.13.5 Ozon Pharmaceuticals Latest Developments
12.14 Patheon
  12.14.1 Company Information
  12.14.2 Large Volume Parenteral (LVP) Product Offered
  12.14.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.14.4 Main Business Overview
  12.14.5 Patheon Latest Developments
12.15 Cook Pharmica
  12.15.1 Company Information
  12.15.2 Large Volume Parenteral (LVP) Product Offered
  12.15.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.15.4 Main Business Overview
  12.15.5 Cook Pharmica Latest Developments
12.16 Beximco Pharma
  12.16.1 Company Information
  12.16.2 Large Volume Parenteral (LVP) Product Offered
  12.16.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.16.4 Main Business Overview
  12.16.5 Beximco Pharma Latest Developments
12.17 Albert David
  12.17.1 Company Information
  12.17.2 Large Volume Parenteral (LVP) Product Offered
  12.17.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.17.4 Main Business Overview
  12.17.5 Albert David Latest Developments
12.18 Aspen Holdings
  12.18.1 Company Information
  12.18.2 Large Volume Parenteral (LVP) Product Offered
  12.18.3 Aspen Holdings Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.18.4 Main Business Overview
  12.18.5 Aspen Holdings Latest Developments
12.19 BML Parenteral Drugs
  12.19.1 Company Information
  12.19.2 Large Volume Parenteral (LVP) Product Offered
  12.19.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2018-2020)
  12.19.4 Main Business Overview
  12.19.5 BML Parenteral Drugs Latest Developments

13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Research Methodology
Table 2. Data Source
Table 3. Large Volume Parenteral (LVP) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Soft Bag LVP
Table 5. Major Players of Plastic Bottle LVP
Table 6. Major Players of Glass Bottle LVP
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Large Volume Parenteral (LVP) Consumption Market Share by Type (2015-2020)
Table 9. Global Large Volume Parenteral (LVP) Revenue by Type (2015-2020) ($ million)
Table 10. Global Large Volume Parenteral (LVP) Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Large Volume Parenteral (LVP) Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Large Volume Parenteral (LVP) Consumption Market Share by Application (2015-2020)
Table 14. Global Large Volume Parenteral (LVP) Value by Application (2015-2020)
Table 15. Global Large Volume Parenteral (LVP) Value Market Share by Application (2015-2020)
Table 16. Global Large Volume Parenteral (LVP) Sale Price by Application (2015-2020)
Table 17. Global Large Volume Parenteral (LVP) Sales by Company (2017-2019) (M Units)
Table 18. Global Large Volume Parenteral (LVP) Sales Market Share by Company (2017-2019)
Table 19. Global Large Volume Parenteral (LVP) Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Large Volume Parenteral (LVP) Revenue Market Share by Company (2017-2019)
Table 21. Global Large Volume Parenteral (LVP) Sale Price by Company (2017-2019)
Table 22. Global Large Volume Parenteral (LVP) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Large Volume Parenteral (LVP) Products Offered
Table 24. Large Volume Parenteral (LVP) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Large Volume Parenteral (LVP) Consumption by Regions 2015-2020 (M Units)
Table 26. Global Large Volume Parenteral (LVP) Consumption Market Share by Regions 2015-2020
Table 27. Global Large Volume Parenteral (LVP) Value by Regions 2015-2020 ($ Millions)
Table 28. Global Large Volume Parenteral (LVP) Value Market Share by Regions 2015-2020
Table 29. Americas Large Volume Parenteral (LVP) Consumption by Countries (2015-2020) (M Units)
Table 30. Americas Large Volume Parenteral (LVP) Consumption Market Share by Countries (2015-2020)
Table 31. Americas Large Volume Parenteral (LVP) Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Large Volume Parenteral (LVP) Value Market Share by Countries (2015-2020)
Table 33. Americas Large Volume Parenteral (LVP) Consumption by Type (2015-2020) (M Units)
Table 34. Americas Large Volume Parenteral (LVP) Consumption Market Share by Type (2015-2020)
Table 35. Americas Large Volume Parenteral (LVP) Consumption by Application (2015-2020) (M Units)
Table 36. Americas Large Volume Parenteral (LVP) Consumption Market Share by Application (2015-2020)
Table 37. APAC Large Volume Parenteral (LVP) Consumption by Countries (2015-2020) (M Units)
Table 38. APAC Large Volume Parenteral (LVP) Consumption Market Share by Countries (2015-2020)
Table 39. APAC Large Volume Parenteral (LVP) Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Large Volume Parenteral (LVP) Value Market Share by Regions (2015-2020)
Table 41. APAC Large Volume Parenteral (LVP) Consumption by Type (2015-2020) (M Units)
Table 42. APAC Large Volume Parenteral (LVP) Consumption Market Share by Type (2015-2020)
Table 43. APAC Large Volume Parenteral (LVP) Consumption by Application (2015-2020) (M Units)
Table 44. APAC Large Volume Parenteral (LVP) Consumption Market Share by Application (2015-2020)
Table 45. Europe Large Volume Parenteral (LVP) Consumption by Countries (2015-2020) (M Units)
Table 46. Europe Large Volume Parenteral (LVP) Consumption Market Share by Countries (2015-2020)
Table 47. Europe Large Volume Parenteral (LVP) Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Large Volume Parenteral (LVP) Value Market Share by Countries (2015-2020)
Table 49. Europe Large Volume Parenteral (LVP) Consumption by Type (2015-2020) (M Units)
Table 50. Europe Large Volume Parenteral (LVP) Consumption Market Share by Type (2015-2020)
Table 51. Europe Large Volume Parenteral (LVP) Consumption by Application (2015-2020) (M Units)
Table 52. Europe Large Volume Parenteral (LVP) Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Large Volume Parenteral (LVP) Consumption by Countries (2015-2020) (M Units)
Table 54. Middle East & Africa Large Volume Parenteral (LVP) Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Large Volume Parenteral (LVP) Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Large Volume Parenteral (LVP) Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Large Volume Parenteral (LVP) Consumption by Type (2015-2020) (M Units)
Table 58. Middle East & Africa Large Volume Parenteral (LVP) Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Large Volume Parenteral (LVP) Consumption by Application (2015-2020) (M Units)
Table 60. Middle East & Africa Large Volume Parenteral (LVP) Consumption Market Share by Application (2015-2020)
Table 61. Large Volume Parenteral (LVP) Distributors List
Table 62. Large Volume Parenteral (LVP) Customer List
Table 63. Global Large Volume Parenteral (LVP) Consumption Forecast by Countries (2021-2025) (M Units)
Table 64. Global Large Volume Parenteral (LVP) Consumption Market Forecast by Regions
Table 65. Global Large Volume Parenteral (LVP) Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Large Volume Parenteral (LVP) Value Market Share Forecast by Regions
Table 67. Global Large Volume Parenteral (LVP) Consumption Forecast by Type (2021-2025) (M Units)
Table 68. Global Large Volume Parenteral (LVP) Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Large Volume Parenteral (LVP) Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Large Volume Parenteral (LVP) Value Market Share Forecast by Type (2021-2025)
Table 71. Global Large Volume Parenteral (LVP) Consumption Forecast by Application (2021-2025) (M Units)
Table 72. Global Large Volume Parenteral (LVP) Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Large Volume Parenteral (LVP) Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Large Volume Parenteral (LVP) Value Market Share Forecast by Application (2021-2025)
Table 75. Baxter Healthcare Product Offered
Table 76. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. Baxter Healthcare Main Business
Table 78. Baxter Healthcare Latest Developments
Table 79. Baxter Healthcare Basic Information, Company Total Revenue (in $ million), Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 80. Huaren Product Offered
Table 81. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. Huaren Main Business
Table 83. Huaren Latest Developments
Table 84. Huaren Basic Information, Company Total Revenue (in $ million), Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 85. Kelun Pharma Product Offered
Table 86. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Kelun Pharma Main Business
Table 88. Kelun Pharma Latest Developments
Table 89. Kelun Pharma Basic Information, Company Total Revenue (in $ million), Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 90. Fresenius Product Offered
Table 91. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Fresenius Main Business
Table 93. Fresenius Latest Developments
Table 94. Fresenius Basic Information, Company Total Revenue (in $ million), Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 95. Teva Pharmaceutical Industries Product Offered
Table 96. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Teva Pharmaceutical Industries Main Business
Table 98. Teva Pharmaceutical Industries Latest Developments
Table 99. Teva Pharmaceutical Industries Basic Information, Company Total Revenue (in $ million), Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 100. B. Braun Product Offered
Table 101. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. B. Braun Main Business
Table 103. B. Braun Latest Developments
Table 104. B. Braun Basic Information, Company Total Revenue (in $ million), Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 105. CR Double-Crane Product Offered
Table 106. CR Double-Crane Basic Information, Company Total Revenue (in $ million), Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 107. CR Double-Crane Main Business
Table 108. CR Double-Crane Latest Developments
Table 109. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. Pfizer (Hospira) Product Offered
Table 111. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Pfizer (Hospira) Main Business
Table 113. Pfizer (Hospira) Latest Developments
Table 114. Pfizer (Hospira) Basic Information, Company Total Revenue (in $ million), Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 115. Pisa Product Offered
Table 116. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Pisa Main Business
Table 118. Pisa Latest Developments
Table 119. Pisa Basic Information, Company Total Revenue (in $ million), Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 120. Ostuka Pharmaceutical Product Offered
Table 121. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Ostuka Pharmaceutical Main Business
Table 123. Ostuka Pharmaceutical Latest Developments
Table 124. Ostuka Pharmaceutical Basic Information, Company Total Revenue (in $ million), Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 125. PSI Ltd Product Offered
Table 126. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. PSI Ltd Main Business
Table 128. PSI Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. PSI Ltd Latest Developments
Table 130. BAG Healthcare Product Offered
Table 131. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 132. BAG Healthcare Main Business
Table 133. BAG Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. BAG Healthcare Latest Developments
Table 135. Ozon Pharmaceuticals Product Offered
Table 136. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 137. Ozon Pharmaceuticals Main Business
Table 138. Ozon Pharmaceuticals Latest Developments
Table 139. Ozon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 140. Patheon Product Offered
Table 141. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 142. Patheon Main Business
Table 143. Patheon Latest Developments
Table 144. Patheon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 145. Cook Pharmica Product Offered
Table 146. Cook Pharmica Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 147. Cook Pharmica Main Business
Table 148. Cook Pharmica Latest Developments
Table 149. Cook Pharmica Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 150. Beximco Pharma Product Offered
Table 151. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 152. Beximco Pharma Main Business
Table 153. Beximco Pharma Latest Developments
Table 154. Beximco Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 155. Albert David Product Offered
Table 156. Albert David Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 157. Albert David Main Business
Table 158. Albert David Latest Developments
Table 159. Albert David Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 160. Aspen Holdings Product Offered
Table 161. Aspen Holdings Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 162. Aspen Holdings Main Business
Table 163. Aspen Holdings Latest Developments
Table 164. Aspen Holdings Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 165. BML Parenteral Drugs Product Offered
Table 166. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 167. BML Parenteral Drugs Main Business
Table 168. BML Parenteral Drugs Latest Developments
Table 169. BML Parenteral Drugs Basic Information, Manufacturing Base, Sales Area and Its Competitors

LIST OF FIGURES

Figure 1. Picture of Large Volume Parenteral (LVP)
Figure 2. Large Volume Parenteral (LVP) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Large Volume Parenteral (LVP) Consumption Growth Rate 2015-2025 (M Units)
Figure 5. Global Large Volume Parenteral (LVP) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Soft Bag LVP
Figure 7. Product Picture of Plastic Bottle LVP
Figure 8. Product Picture of Glass Bottle LVP
Figure 9. Global Large Volume Parenteral (LVP) Consumption Market Share by Type (2015-2020)
Figure 10. Global Large Volume Parenteral (LVP) Value Market Share by Type (2015-2020)
Figure 11. Large Volume Parenteral (LVP) Consumed in Basic Infusion
Figure 12. Global Large Volume Parenteral (LVP) Market: Basic Infusion (2015-2020) (M Units)
Figure 13. Global Large Volume Parenteral (LVP) Market: Basic Infusion (2015-2020) ($ Millions)
Figure 14. Large Volume Parenteral (LVP) Consumed in Therapeutic Infusion
Figure 15. Global Large Volume Parenteral (LVP) Market: Therapeutic Infusion (2015-2020) (M Units)
Figure 16. Global Large Volume Parenteral (LVP) Market: Therapeutic Infusion (2015-2020) ($ Millions)
Figure 17. Large Volume Parenteral (LVP) Consumed in Nutritious Infusion
Figure 18. Global Large Volume Parenteral (LVP) Market: Nutritious Infusion (2015-2020) (M Units)
Figure 19. Global Large Volume Parenteral (LVP) Market: Nutritious Infusion (2015-2020) ($ Millions)
Figure 20. Global Large Volume Parenteral (LVP) Consumption Market Share by Application (2015-2020)
Figure 21. Global Large Volume Parenteral (LVP) Value Market Share by Application (2015-2020)
Figure 22. Global Large Volume Parenteral (LVP) Sales Market Share by Company in 2017
Figure 23. Global Large Volume Parenteral (LVP) Sales Market Share by Company in 2019
Figure 24. Global Large Volume Parenteral (LVP) Revenue Market Share by Company in 2017
Figure 25. Global Large Volume Parenteral (LVP) Revenue Market Share by Company in 2019
Figure 26. Global Large Volume Parenteral (LVP) Sale Price by Company in 2019
Figure 27. Global Large Volume Parenteral (LVP) Consumption Market Share by Regions 2015-2020
Figure 28. Global Large Volume Parenteral (LVP) Value Market Share by Regions 2015-2020
Figure 29. Americas Large Volume Parenteral (LVP) Consumption 2015-2020 (M Units)
Figure 30. Americas Large Volume Parenteral (LVP) Value 2015-2020 ($ Millions)
Figure 31. APAC Large Volume Parenteral (LVP) Consumption 2015-2020 (M Units)
Figure 32. APAC Large Volume Parenteral (LVP) Value 2015-2020 ($ Millions)
Figure 33. Europe Large Volume Parenteral (LVP) Consumption 2015-2020 (M Units)
Figure 34. Europe Large Volume Parenteral (LVP) Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Large Volume Parenteral (LVP) Consumption 2015-2020 (M Units)
Figure 36. Middle East & Africa Large Volume Parenteral (LVP) Value 2015-2020 ($ Millions)
Figure 37. Americas Large Volume Parenteral (LVP) Consumption Market Share by Countries in 2019
Figure 38. Americas Large Volume Parenteral (LVP) Value Market Share by Countries in 2019
Figure 39. Americas Large Volume Parenteral (LVP) Consumption Market Share by Type in 2019
Figure 40. Americas Large Volume Parenteral (LVP) Consumption Market Share by Application in 2019
Figure 41. United States Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 42. United States Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 44. Canada Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 46. Mexico Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Large Volume Parenteral (LVP) Consumption Market Share by Countries in 2019
Figure 48. APAC Large Volume Parenteral (LVP) Value Market Share by Regions in 2019
Figure 49. APAC Large Volume Parenteral (LVP) Consumption Market Share by Type in 2019
Figure 50. APAC Large Volume Parenteral (LVP) Consumption Market Share by Application in 2019
Figure 51. China Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 52. China Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 54. Japan Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 56. Korea Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 58. Southeast Asia Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 59. India Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 60. India Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 62. Australia Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Large Volume Parenteral (LVP) Consumption Market Share by Countries in 2019
Figure 64. Europe Large Volume Parenteral (LVP) Value Market Share by Countries in 2019
Figure 65. Europe Large Volume Parenteral (LVP) Consumption Market Share by Type in 2019
Figure 66. Europe Large Volume Parenteral (LVP) Consumption Market Share by Application in 2019
Figure 67. Germany Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 68. Germany Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 69. France Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 70. France Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 71. UK Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 72. UK Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 74. Italy Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 76. Russia Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Large Volume Parenteral (LVP) Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Large Volume Parenteral (LVP) Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Large Volume Parenteral (LVP) Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Large Volume Parenteral (LVP) Consumption Market Share by Application in 2019
Figure 81. Egypt Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 82. Egypt Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 84. South Africa Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 86. Israel Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 88. Turkey Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Large Volume Parenteral (LVP) Consumption Growth 2015-2020 (M Units)
Figure 90. GCC Countries Large Volume Parenteral (LVP) Value Growth 2015-2020 ($ Millions)
Figure 91. Global Large Volume Parenteral (LVP) Consumption Growth Rate Forecast (2021-2025) (M Units)
Figure 92. Global Large Volume Parenteral (LVP) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 94. Americas Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 95. APAC Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 96. APAC Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 97. Europe Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 98. Europe Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 100. Middle East & Africa Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 101. United States Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 102. United States Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 103. Canada Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 104. Canada Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 105. Mexico Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 106. Mexico Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 107. Brazil Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 108. Brazil Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 109. China Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 110. China Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 111. Japan Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 112. Japan Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 113. Korea Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 114. Korea Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 116. Southeast Asia Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 117. India Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 118. India Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 119. Australia Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 120. Australia Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 121. Germany Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 122. Germany Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 123. France Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 124. France Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 125. UK Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 126. UK Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 127. Italy Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 128. Italy Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 129. Russia Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 130. Russia Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 131. Spain Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 132. Spain Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 133. Egypt Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 134. Egypt Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 135. South Africa Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 136. South Africa Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 137. Israel Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 138. Israel Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 139. Turkey Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 140. Turkey Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Large Volume Parenteral (LVP) Consumption 2021-2025 (M Units)
Figure 142. GCC Countries Large Volume Parenteral (LVP) Value 2021-2025 ($ Millions)
Figure 143. Baxter Healthcare Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 144. Huaren Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 145. Kelun Pharma Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 146. Fresenius Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 147. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 148. B. Braun Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 149. CR Double-Crane Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 150. Pfizer (Hospira) Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 151. Pisa Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 152. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 153. PSI Ltd Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 154. BAG Healthcare Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 155. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 156. Patheon Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 157. Cook Pharmica Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 158. Beximco Pharma Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 159. Albert David Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 160. Aspen Holdings Large Volume Parenteral (LVP) Market Share (2018-2020)
Figure 161. BML Parenteral Drugs Large Volume Parenteral (LVP) Market Share (2018-2020)


More Publications